These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8618872)

  • 1. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.
    Diebold RJ; Eis MJ; Yin M; Ormsby I; Boivin GP; Darrow BJ; Saffitz JE; Doetschman T
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12215-9. PubMed ID: 8618872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
    Geiser AG; Letterio JJ; Kulkarni AB; Karlsson S; Roberts AB; Sporn MB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9944-8. PubMed ID: 8234339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse.
    Kobayashi S; Yoshida K; Ward JM; Letterio JJ; Longenecker G; Yaswen L; Mittleman B; Mozes E; Roberts AB; Karlsson S; Kulkarni AB
    J Immunol; 1999 Oct; 163(7):4013-9. PubMed ID: 10491004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of IFN-gamma signaling pathways in the absence of TGF-beta 1.
    McCartney-Francis NL; Wahl SM
    J Immunol; 2002 Nov; 169(10):5941-7. PubMed ID: 12421979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
    Kulkarni AB; Huh CG; Becker D; Geiser A; Lyght M; Flanders KC; Roberts AB; Sporn MB; Ward JM; Karlsson S
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):770-4. PubMed ID: 8421714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.
    Letterio JJ; Geiser AG; Kulkarni AB; Dang H; Kong L; Nakabayashi T; Mackall CL; Gress RE; Roberts AB
    J Clin Invest; 1996 Nov; 98(9):2109-19. PubMed ID: 8903331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats.
    Nicoletti A; Mandet C; Challah M; Bariéty J; Michel JB
    Cardiovasc Res; 1996 Apr; 31(4):585-95. PubMed ID: 8689650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal rescue of transforming growth factor-beta 1 null mice.
    Letterio JJ; Geiser AG; Kulkarni AB; Roche NS; Sporn MB; Roberts AB
    Science; 1994 Jun; 264(5167):1936-8. PubMed ID: 8009224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
    Shull MM; Ormsby I; Kier AB; Pawlowski S; Diebold RJ; Yin M; Allen R; Sidman C; Proetzel G; Calvin D
    Nature; 1992 Oct; 359(6397):693-9. PubMed ID: 1436033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune dysregulation in TGF-beta 1-deficient mice.
    Christ M; McCartney-Francis NL; Kulkarni AB; Ward JM; Mizel DE; Mackall CL; Gress RE; Hines KL; Tian H; Karlsson S
    J Immunol; 1994 Sep; 153(5):1936-46. PubMed ID: 8051399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice.
    Su HC; Ishikawa R; Biron CA
    J Immunol; 1993 Nov; 151(9):4874-90. PubMed ID: 8409446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of oral tolerance in TGF-beta 1 null mice.
    Barone KS; Tolarova DD; Ormsby I; Doetschman T; Michael JG
    J Immunol; 1998 Jul; 161(1):154-60. PubMed ID: 9647219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.
    Kania G; Blyszczuk P; Stein S; Valaperti A; Germano D; Dirnhofer S; Hunziker L; Matter CM; Eriksson U
    Circ Res; 2009 Aug; 105(5):462-70. PubMed ID: 19628793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.
    Nakabayashi T; Sakata KM; Sakata A; Kong L; Lau CA; Letterio JJ; Vela-Roch N; Talal N; Dang H
    Inflammation; 2001 Apr; 25(2):69-73. PubMed ID: 11321361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine expression of the active form of TGF-beta1 in the TGF-beta1 null mice fails to ameliorate lethal phenotype.
    Longenecker G; Thyagarajan T; Nagineni CN; Flanders KC; Factor V; Miller G; Ward JM; Nalca A; Rangnekar VM; Thorgeirsson S; Kulkarni AB
    Cytokine; 2002 Apr; 18(1):43-50. PubMed ID: 12090759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model.
    Scherf W; Burdach S; Hansen G
    Eur J Immunol; 2005 Jan; 35(1):198-206. PubMed ID: 15593298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed wound healing in immunodeficient TGF-beta 1 knockout mice.
    Crowe MJ; Doetschman T; Greenhalgh DG
    J Invest Dermatol; 2000 Jul; 115(1):3-11. PubMed ID: 10886500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta (TGF-beta) and autoimmunity.
    Aoki CA; Borchers AT; Li M; Flavell RA; Bowlus CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Sep; 4(7):450-9. PubMed ID: 16137611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.
    Boivin GP; O'Toole BA; Orsmby IE; Diebold RJ; Eis MJ; Doetschman T; Kier AB
    Am J Pathol; 1995 Jan; 146(1):276-88. PubMed ID: 7856734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice.
    Nakabayashi T; Letterio JJ; Geiser AG; Kong L; Ogawa N; Zhao W; Koike T; Fernandes G; Dang H; Talal N
    J Immunol; 1997 Jun; 158(11):5527-35. PubMed ID: 9164977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.